We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CYTK market cap is 5.83B. The company's latest EPS is USD -4.4592 and P/E is -11.07.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 867k | 378k | 1.67M | 835k | 249k |
| Operating Income | -122.05M | -122.27M | -127.42M | -126.24M | -130.17M |
| Net Income | -128.64M | -129.42M | -136.9M | -135.64M | -143.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 26.87M | 55.83M | 70.43M | 94.59M | 7.53M |
| Operating Income | -98.87M | -93.94M | -186.34M | -324.2M | -496.21M |
| Net Income | -121.69M | -127.29M | -215.34M | -388.96M | -526.24M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 779.9M | 740.61M | 824.32M | 808.08M | 1.52B |
| Total Liabilities | 1.11B | 1.18B | 1.21B | 1.2B | 1.42B |
| Total Equity | -333.12M | -438.8M | -386.32M | -396.16M | 108.55M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 289.81M | 533.8M | 841.32M | 1.01B | 824.32M |
| Total Liabilities | 300.75M | 420.42M | 597.46M | 1.12B | 1.21B |
| Total Equity | -10.94M | 113.38M | 243.86M | -107.9M | -386.32M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -244.09M | -340.3M | -414.33M | -129.51M | -228.82M |
| Investing | 247.63M | 320.66M | 239.25M | 32.64M | -618.91M |
| Financing | -1.7M | 52.52M | 221.32M | 103.79M | 924.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -90.91M | 8.94M | -142.52M | -299.52M | -414.33M |
| Investing | -74.71M | -196.52M | -147.78M | -262.13M | 239.25M |
| Financing | 159.79M | 234.12M | 319.98M | 516.17M | 221.32M |
| Market Cap | 5.83B |
| Price to Earnings Ratio | -11.07 |
| Price to Sales Ratio | 773.82 |
| Price to Cash Ratio | 51.55 |
| Price to Book Ratio | -15.08 |
| Dividend Yield | - |
| Shares Outstanding | 118.01M |
| Average Volume (1 week) | 902.22k |
| Average Volume (1 Month) | 1.13M |
| 52 Week Change | -40.88% |
| 52 Week High | 110.25 |
| 52 Week Low | 45.66 |
| Spread (Intraday) | 1.46 (2.89%) |
| Company Name | Cytokinetics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cytokinetics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
